Ask AI
ASCENT-03
ASCENT-03: Phase III Trial of 1L Sacituzumab Govitecan vs Chemotherapy for Patients With Advanced TNBC Ineligible for PD-1/PD-L1 Inhibitors

Released: October 24, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: October 24, 2025